Bladder and urinary disorders Flashcards
Urinary incontinence: treatment (women)
Urge incontinence:
- First line: Bladder training - 6 weeks →
- Antimuscarinic drugs (oxybutynin, tolterodine) →
- Mirabegron
Stress incontinence:
- First line: pelvic floor training - 3M →
- Duloxetine
Urinary incontinence: drugs
Antimuscarinics
- Oxybutynin (available as transdermal patch)
- Tolterodine
- Solifenacin
Beta3 agonist
- Mirabegron (CI: severe uncontrolled HT)
Other
- Duloxetine (SNRI, avoid abrupt withdrawal)
Nocturnal enuresis: treatment 5+ years
First line: enuresis alarms (continue til 2 weeks of dry nights) →
Desmopressin (oral or sublingual)
- Counsel: avoid fluid overload (inc swimming), restrict fluid intake 1h before + 8h after
- Stop desmopressin if vomiting or diarrhoea
Urinary retention: treatment
- Alpha blockers
- 5a-reductase inhibitors (raised prostate specific antigen + high risk of progression)
Alpha blocker: MOA
blocks alpha 1 adrenoreceptors; relaxes bladder + prostate gland
Alpha blocker: indication
- Benign prostatic hyperplasia
- Hypertension
Alpha blocker: drugs
- Alfuzosin (BPH only)
- Tamsulosin (BPH only)
- Doxazosin
Alpha blocker: side effect
Postural hypotension
- Dizzy, blurred vision, fainting, tachycardia
- Counsel: take first dose at bedtime, driving can be impaired
- CI: postural hypotension
Finasteride/dutasteride: MOA
5a reductase inhibitor; prevents metabolism of testosterone into dihydrotestosterone
Finasteride/dutasteride: indication
- Benign prostatic hyperplasia
- Male pattern baldness
Finasteride/dutasteride: side effect
Male breast cancer
- Counsel: report breast symptoms (breast pain, lumps, nipple discharge)
Finasteride: Suicidal thoughts + ED
- MHRA: reminder of risk of psychiatric + sexual side effects, patient alert card
- Counsel: stop and report depression
- Counsel: report sexual dysfunction (inability to get or maintain erection, reduced sex drive)
Finasteride/dutasteride: pregnancy
Teratogenic